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loss among patients with severe vernal keratoconjunctivitis (VKC).
Methods: Four hundred and thirty-one patients with VKC seen at Ibn Al-Haitham Eye Center
were the study group. This is a retrospective non-comparative observational study between 01 Jan-
uary 2002 and 31 December 2002. Visual acuity was measured with the standard Snellen visual acu-
ity chart and for children under 5 years of age Kay pictures were used. Visual impairment was
assessed by means of the World Health Organization criteria for visual disabilities. Cases with
severe VKC that developed ocular complications leading to blindness and severe visual impairment
were analyzed.
Results: The majority of VKC patients were males (75.9%) with a male:female ratio of 3.1:1. A
total of 68 (15.7%) patients (54 boys and 14 girls) had severe VKC. The ocular ﬁndings amongconference of Clinical Immu-
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292 S.A. Al-Akily, M.A. Bamashmus20 patients with severe VKC that led to blindness and severe visual impairment included keratoco-
nus (7); steroid-induced cataract (5), central corneal scars (5) and steroid-induced glaucoma (3).
Two of the keratoconus cases developed acute hydrops.
Conclusion: Severe VKC in developing countries including Yemen is a potentially blinding disease.
Visual loss may be due to keratoconus and corneal scars, as well as complications of the unsuper-
vised use of topically administered corticosteroids.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The eye is a frequent target of inﬂammation in both local and
systemic allergic reactions. The vast majority of ocular allergy
affects the conjunctiva. Vernal keratoconjunctivitis (VKC) is a
severe form of ocular allergic conjunctivitis causing
disturbance of normal activities at school or work due to se-
vere itching, grittiness, foreign body sensation, difﬁculty in
opening the eyelids, photophobia and copious mucous
discharge (Kosrirukvongs et al., 2001).
VKC is a potentially severe, chronic, allergic condition,
causing bilateral recurrent inﬂammatory disorder of the con-
junctiva and cornea. Typically occurs in males before the age
of 10 in 80% of cases, it lasts 2–10 years, and it usually resolves
during puberty. Males have an earlier presentation of symp-
toms than females and the male to female ratio decreases with
age (Bonini et al., 2004).
VKC is more prevalent in hot and dry areas (Mediterra-
nean basin, the Middle East, Africa and the Indian subconti-
nent). It is relatively unusual in most of North America and
Western Europe (Bremond-Gignac et al., 2008). Risk factors
include age, underlying atopic predisposition, extent of aller-
gen exposure and individual immune response to antigenic
stimulation. There is a signiﬁcant history of other atopic man-
ifestations such as eczema or asthma in patients with VKC
(Ajaiyeoba, 2003). A family history of atopy is found in these
patients.
Three types of VKC are recognized. Limbal type (ﬁne
papillae with circumferential gelatinous limbal inﬁltration
and Horner-Trantas dots); the palpebral type (giant papillae
of >1 mm in diameter on the superior tarsal conjunctiva)
and a mixed type. These features leave no doubt as to the diag-
nosis of VKC. The reasons underlying the development of the
various types of VKC in these patients are not understood
(Kumar, 2009).
The main symptoms are itching; redness and foreign body
sensation. Lacrimation; photophobia; blepharospasm and
pseudo-ptosis due to palpebral thickening are highly speciﬁc
symptoms of VKC. These symptoms if not treated appropri-
ately can persist for weeks (Leonardi and Secchi, 2003). Sea-
sonal exacerbation is common, but patients may have
symptoms year-round especially those living in subtropical
or desert climates. More than 60% of patients have repeated
recurrences all year round (seasonal variation) and this led
to the widely accepted hypothesis that VKC is an immunolog-
ically mediated hypersensitivity reaction to environmental
antigens (Leonardi, 2002).
The signs include papillary response of the conjunctiva,
principally of the limbus or upper tarsus; thick, abundant
and ropy mucus; Trantas dots and ‘‘cobblestone papillae’’.
Keratitis (which occurs in up to 50% of cases) (Iqbal et al.,
2003) and shield ulcers are sight-threatening complications.There is an association of Keratoconus in VKC patients
(Totan et al., 2001). Other risks are of cataract and glaucoma
due to the steroids. VKC may cause signiﬁcant complications
and lead to loss of vision (Bremond-Gignac et al., 2008; Bonini
et al., 2003).
Although several studies have been published on this dis-
ease, only few dealt with the visual problems and ocular com-
plications of VKC. The purpose of this study was to assess the
ocular complications and visual loss among patients with se-
vere VKC in Yemen.
2. Patients and methods
This is a retrospective non-comparative observational study
done in Ibn Al-Haitham Eye Center which is afﬁliated to the
University of Science and Technology in Sana’a, Yemen.
The study was done between 01 January 2002 and 31 Decem-
ber 2002.
Four hundred and thirty-one consecutive patients (431)
with VKC were the study group during the study period. Inclu-
sion criteria were recurrent bilateral symptomatic VKC with
conjunctival giant papillae formation at the superior tarsus
and/or limbus as the hallmark of the disease and the presence
of persistent and recurrent symptoms of conjunctivitis. A sim-
ple clinical score by Bonini et al. (2004) was used for disease
severity classiﬁcation. Patients were deemed to have severe
VKC if they had had persistent symptoms and signs (diffuse
palpebral conjunctival edema; thickening with papillary hyper-
trophy (P3); giant papillary conjunctivitis and had limbal inﬁl-
tration of 180 or more). Cases with allergic conjunctivitis
other than VKC were excluded from the study.
Data collected included best spectacle corrected visual acu-
ity (BSCVA) to each eye using Snellen’s projection chart. For
children under the age of 5 years Kay pictures were used. The
World Health Organization (WHO) criteria for visual disabil-
ities were used to assess visual impairment. The WHO recom-
mended deﬁnitions of visual impairment and blindness, where
normal vision, mild visual impairment, severe visual impair-
ment and blindness were deﬁned as visual acuity (VA) of 6/
6–6/18; 6/24–6/60; <6/60 to 3/60 and <3/60, respectively.
Best corrected visual acuity used was in the better eye.
Haag Streit slitlamp bio-microscopy for anterior segment
examination, +90 Dioptre Volk lens for fundal examination
and Zeiss Goldmann applanation tonometry information were
retrieved from the case notes. Case notes of patients with vi-
sual acuity (VA) 3/60–6/60 in the better eye (severe visual
impairment) or <3/60 (blind) were selected for more extensive
chart review to establish the main cause of severe visual
impairment or blindness.
Descriptive analysis was performed on the data collected
using Microsoft Excel spreadsheet 2003 (Microsoft Corpora-
tion, Seattle, USA).
Figure 1 Visual acuity in the 68 patients with severe vernal
keratoconjunctivitis.
Figure 2 Causes of poor vision in patients with severe vernal
keratoconjunctivitis (20 patients).
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mittee of Ibn Al-Haitham Eye Center and the procedures fol-
lowed were in accordance with the ethical standards of the
responsible committee on human experimentation (institu-
tional or regional) and with the Helsinki Declaration of
1975, as revised in 2000.
3. Results
The majority of VKC patients (n= 431) were males (n= 327)
and females (n= 104) with a male:female ratio of 3.1:1. Table 1
shows the age distribution of the patients with VKC. Gender
distribution, clinical forms and age of onset are shown in
Table 2. All cases had bilateral disease.
A total of 68 (15.7%) patients (54 boys and 14 girls) had se-
vere VKC. Fig. 1 shows the visual acuity among the 68 patients
with severe VKC. Visual loss among 20 patients with blindness
and severe visual impairment included keratoconus (7),
steroid-induced cataract (5), central corneal scars (5) and ste-
roid-induced glaucoma (3) (Fig. 2). Keratoconus was progres-
sive in many patients, resulting in visual loss, often not
correctable with glasses or contact lenses. Two of the keratoco-
nus cases developed acute hydrops.
4. Discussion
Allergic eye diseases including vernal keratoconjunctivitis
(VKC) are common diseases in the Mediterranean region
including Yemen (Lambiase et al., 2009). In Nigeria, VKC
was identiﬁed as the most common conjunctival disease in chil-
dren seen in hospital (Ukponmwan, 2003). A study done by
Farouk et al. (2005) in Kuwait University Hospital in Sana’a,
Yemen showed that allergic eye diseases are the second most
common diagnosis in the eye clinics after refractive errors.
Majority of cases with VKC examined in this study were
younger than 10 years. (49.2%) while still the disease persists
to the adult age in a number of patients after the age of
20 years (1.9%).
Majority of cases were males (75.9%) with male to female
ratio of 3.1:1 and that is similar to studies from Italy and Thai-Table 1 Age distribution of 431 vernal keratoconjunctivitis
patients in Yemen study.
Age (years) Male Female Total
0–4 25 7 32
5–9 131 49 180
10–14 110 34 144
15–19 56 11 67
>20 5 3 8
Total 327 104 431
Table 2 Details of 431 vernal keratoconjunctivitis patients in Yem
Total (%) Palpebral form (%) Limb
Male 327 (75.9) 128 (39.1) 146 (4
Female 104 (24.1) 19 (18.3) 61 (58
Total 431 (100) 147 (34.1) 207 (4land (Lambiase et al., 2009; Leonardi et al., 2006; Kos-
rirukvongs et al., 2003).
Diagnosis of VKCwas based on the patient’s history and the
presence of typical clinical signs and symptoms. The most com-
mon clinical type of VKC in this study was the limbal type fol-
lowed by the palpebral type and is the same as reported in other
studies (Lambiase et al., 2009; Kosrirukvongs et al., 2003).
Fortunately majority of cases have the mild and moderate
form of VKC. Severe VKC accounted for 15.7% of the studied
group and that is slightly more than the case series published
by Leonardi et al. (2006) (7.8%) and Lambiase et al. (2009)
(10%).
The ocular complications leading to blindness and severe
visual impairment affected 20 patients (4.6%) and that is sim-
ilar compared to studies (Bremond-Gignac et al., 2008). In a
study by Tabbara in Saudi Arabia (Tabbara, 1999), 21%
had a BSCVA of 20/200 or less due to steroid-induced cata-en study.
al form (%) Mixed form (%) Age at onset (years)
4.7) 53 (16.2) 6.5 ± 5 (1–24)
.7) 24 (23.0) 7.5 ± 5 (1–25)
8.0) 77 (17.9) 7.0 ± 5 (1–25)
294 S.A. Al-Akily, M.A. Bamashmusract, steroid-induced glaucoma, central corneal scars, irregular
astigmatism and keratoconus.
Therapy for mild VKC includes preservative-free artiﬁcial
tears, cold compresses and antihistamines. Treatment in severe
cases of VKC is still problematic due to frequent exacerba-
tions. Topical corticosteroids are usually given only for a short
period of time to avoid the risk of side effects including glau-
coma, cataract and infection (Kumar, 2009). Unfortunately
patients and their relatives keep seeing more than one doctor
looking for cure from the disease and this leads to the pro-
longed unsupervised use of steroid drops and increasing the
risk of complications.
Cyclosporine drops have good effect in VKC cases with
fewer side effects (Gupta and Sahu, 2001) compared to cortico-
steroids but unfortunately it is not available in Yemen. A close
ophthalmological supervision with controlled discontinuous
treatment according to the disease severity is essential to avoid
self-prescription and misuse of steroid drops.
Limitations of this study are: there were no immunological
diagnostic tests done to this group of patients because of lim-
itations in the facilities available in Yemen. History of other
associated allergic diseases and family history of allergic dis-
eases were not documented in this study. Also patients were
not grouped to those who come from desert areas or the moun-
tains to study the differences in presentations and ocular
complications.5. Conclusions
VKC is not a rare disease in Yemen, and the severe form of
VKC is a potentially blinding disease and carries signiﬁcant
societal costs. There is a need to a disease severity grading in
order to develop standardized therapeutic guidelines based
on the stage of VKC. Visual loss may be due to keratoconus
and corneal scars, as well as complications of the unsupervised
use of topically administered steroids.Acknowledgments
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